MONISTAT
Pronunciation: mi-KON-a-zoel

What it isImidazole CYP51 inhibitor; cutaneous, vulvovaginal, and oropharyngeal fungal infections.
Why this oneIts topical, vaginal, and buccal formulations treat local disease with little systemic exposure.
What limits it⚑ Even vaginal or buccal use can potentiate warfarin enough to cause bleeding; local irritation is common.
Animated chart of estimated U.S. prescriptions per year, Antifungals (1947–2026). Miconazole enters in 1974 (estimated).
Principal riskEven topical forms raise warfarin enough to cause bleeding
Legacy pregnancy categoryC
Defining liabilityLocal irritation or hypersensitivity; systemic toxicity is minimal with correct local use.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Vaginal yeast infection | ≥12 yr | 1 applicatorful intravaginally QHS ×7 nights | ||
| External vulvar itching/irritation | ≥12 yr | apply to vulva BID ×up to 7 days PRN |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 2 % | cream | per unit | not offered | |
| 4 % | cream | per unit | not offered | |
| 100 mg | supp | per unit | not offered | |
| 200 mg | supp | per unit | $13.89/ea | offered |
Generic entry1992
Open Miconazole in the interactive console ↗